Hiromichi Kawai
Overview
Explore the profile of Hiromichi Kawai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ong S, Funayama M, Mangyoku Y, Kawai H, Yoshino H, Li Y, et al.
Mov Disord
. 2023 Dec;
39(3):626-627.
PMID: 38146173
No abstract available.
2.
Shimizu Y, Kitamura A, Tsukamoto T, Kim H, Kawai H, Urushitani M
Rinsho Shinkeigaku
. 2019 May;
59(5):253-257.
PMID: 31061299
A 69-year-old man was admitted because of subacute development of lower limb weakness from one month ago. He showed central obesity, gynecomastia, dorsal fat pad ("buffalo hump"), and proximal muscle...
3.
Hikiami R, Yamashita H, Koita N, Jingami N, Sawamoto N, Furukawa K, et al.
J Hum Genet
. 2017 Dec;
63(1):89-92.
PMID: 29215088
Axonal Charcot-Marie-Tooth disease (CMT) is most frequently caused by mutations in the MFN2 gene (CMT2A) that can lead to various clinical phenotypes. The age at disease onset varies, but most...
4.
Kim H, Oi J, Yamakawa I, Kawai H
Neurology
. 2016 Dec;
87(24):2602.
PMID: 27956568
No abstract available.
5.
Clinical Phenotype and Segregation of Mitochondrial 3243A>G Mutation in 2 Pairs of Monozygotic Twins
Maeda K, Kawai H, Sanada M, Terashima T, Ogawa N, Idehara R, et al.
JAMA Neurol
. 2016 Jun;
73(8):990-3.
PMID: 27323007
Importance: The regulatory factors explaining the wide spectrum of clinical phenotypes for mitochondrial 3243A>G mutation are not known. Crosstalk between nuclear genes and mitochondrial DNA might be one factor. Observations:...
6.
Araki S, Haneda M, Koya D, Kondo K, Tanaka S, Arima H, et al.
Clin J Am Soc Nephrol
. 2015 Nov;
10(12):2152-8.
PMID: 26563378
Background And Objectives: We investigated the association of urinary potassium and sodium excretion with the incidence of renal failure and cardiovascular disease in patients with type 2 diabetes. Design, Setting,...
7.
Kume S, Araki S, Ono N, Shinhara A, Muramatsu T, Araki H, et al.
PLoS One
. 2014 Jun;
9(6):e101219.
PMID: 24971671
Prevention of cardiovascular disease (CVD) is an important therapeutic object of diabetes care. This study assessed whether an index based on plasma free amino acid (PFAA) profiles could predict the...
8.
Terashima T, Kojima H, Urabe H, Yamakawa I, Ogawa N, Kawai H, et al.
J Neurosci Res
. 2014 Jun;
92(7):856-69.
PMID: 24936617
Amyotrophic lateral sclerosis (ALS) is a progressive disease associated with motor neuron death. Several experimental treatments, including cell therapy using hematopoietic or neuronal stem cells, have been tested in ALS...
9.
Nakao K, Uzu T, Araki S, Kume S, Deji N, Chin-Kanasaki M, et al.
J Diabetes Investig
. 2014 May;
3(1):86-91.
PMID: 24843550
Unlabelled: Aims/Introduction: Although increases in urinary protein excretion generally precede a decline in the glomerular filtration rate, non-proteinuric renal impairment is common in patients with diabetes. In the present study,...
10.
Ogawa N, Kawai H, Terashima T, Kojima H, Oka K, Chan L, et al.
PLoS One
. 2014 Mar;
9(3):e92073.
PMID: 24642694
Neuropathic pain can be a debilitating condition. Many types of drugs that have been used to treat neuropathic pain have only limited efficacy. Recent studies indicate that pro-inflammatory mediators including...